Peptide Therapeutics for COVID-19

As the world struggles to cope with the current COVID-19 pandemic, in this edition of “Peptide Highlights” we present a survey of peptide drugs which are being investigated as potential therapies for the disease.

For more please download PDF file.

Contributed by Susan J. Tzotzos

Susan Tzotzos works for the Vienna-based biotech company Apeptico Forschung & Entwicklung GmbH, where she designs therapeutic peptides, oversees their synthesis and follows up their application in clinical trials. Susan also manages various research collaborations with university departments carrying out projects investigating the mode of action of Apeptico’s therapeutic peptides.

Title: Tzotzos_Sep_2020 (717 clicks)
Filename: tzotzos_sep_2020.pdf
Size: 220 KB